Healthy volunteers test new combo cancer pill
NCT ID NCT07141511
First seen Nov 17, 2025 · Last updated Jun 15, 2026 · Updated 26 times
Summary
This study tested a new pill that combines two drugs (zanubrutinib and sonrotoclax) used to treat blood cancers. 24 healthy adults took the pill to see how well it is absorbed by the body, both with and without food. The goal was to compare the combination pill to taking the two drugs separately. No treatment benefit was expected for participants, as the study was only about measuring drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Linear Early Phase
Joondalup, Western Australia, WA 6027, Australia
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.